Tower Research Capital LLC (TRC) - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 1 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$37,127
-94.3%
976
-86.5%
0.00%
-95.5%
Q2 2023$656,740
+386217.6%
7,209
+180.4%
0.02%
+340.0%
Q1 2023$170
+286.4%
2,571
+199.3%
0.01%
+150.0%
Q4 2022$44
-100.0%
859
-89.9%
0.00%
-77.8%
Q3 2022$584,000
-14.5%
8,545
-43.4%
0.01%
-40.0%
Q2 2022$683,000
+21.5%
15,099
+36.4%
0.02%
+200.0%
Q1 2022$562,000
+4.3%
11,066
-3.1%
0.01%
-44.4%
Q4 2021$539,000
+1.3%
11,416
-29.3%
0.01%
-35.7%
Q3 2021$532,000
+64.7%
16,144
+215.9%
0.01%
+75.0%
Q2 2021$323,000
+118.2%
5,111
+48.2%
0.01%
+300.0%
Q1 2021$148,000
+48.0%
3,449
+97.7%
0.00%
-33.3%
Q4 2020$100,000
+9.9%
1,745
-41.9%
0.00%
+200.0%
Q3 2020$91,000
-67.8%
3,005
-65.3%
0.00%
-91.7%
Q2 2020$283,000
+3437.5%
8,652
+3104.4%
0.01%
+1100.0%
Q4 2019$8,000
-93.5%
270
-94.8%
0.00%
-87.5%
Q3 2019$124,000
+217.9%
5,175
+238.9%
0.01%
+166.7%
Q2 2019$39,000
-18.8%
1,527
-43.5%
0.00%
-25.0%
Q3 2018$48,000
+433.3%
2,704
+567.7%
0.00%
+300.0%
Q1 2018$9,0004050.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
venBio Partners LLC 1,526,122$29,759,00024.10%
Cormorant Asset Management, LP 3,600,000$70,200,0004.74%
SECTORAL ASSET MANAGEMENT INC 1,727,829$33,693,0004.05%
Hillhouse Capital Management 2,098,581$40,922,0001.71%
HHLR ADVISORS, LTD. 2,579,708$50,304,0001.40%
CLOUGH CAPITAL PARTNERS L P 589,734$11,500,0001.01%
Vivo Capital, LLC 383,538$7,479,0000.75%
Opaleye Management Inc. 115,000$2,243,0000.62%
Virtus ETF Advisers LLC 14,338$280,0000.60%
Eversept Partners, LP 104,349$2,034,8060.59%
View complete list of APELLIS PHARMACEUTICALS INC shareholders